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PURPOSE. Advanced glycation endproducts (AGEs) have been suggested to play a role in retinal
redetachment by promoting proliferative vitreoretinopathy (PVR). The purpose of this study
was to investigate whether AGEs, in combination with other clinical characteristics, were able
to identify patients at high risk for redetachment after vitrectomy for rhegmatogenous retinal
detachment (RRD).
METHODS. In this prospective cohort study, 410 RRD patients were included. Skin
autofluorescence (SAF), as a reflection of tissue AGE accumulation, was measured by the
AGE Reader. In a subgroup of 90 patients, the well characterised AGEs Ne-(carboxymethyl)ly-
sine (CML), Ne-(carboxyethyl)lysine (CEL), 5-hydro-5-methylimidazolone (MG-H1), and
pentosidine, and the a-dicarbonyls methylglyoxal, glyoxal, and 3-deoxyglucosone were
measured in vitreous biopsies using ultra- or high-performance liquid chromatography. The
main outcome was retinal redetachment within 3 months after surgery.
RESULTS. Fifty-three patients developed a redetachment (aged 64 6 9.6, 64% male) and were
compared with 352 patients without a redetachment (aged 61 6 9.4, 69% male); five patients
were excluded for various reasons. Univariable analysis revealed that SAF, vitreous AGEs, and
vitreous a-dicarbonyls were not significantly elevated in patients with a redetachment.
Multivariable logistic regression analysis showed that surface area of detachment greater than
50% (odds ratio [OR] 2.74, confidence interval [CI] 1.45–5.17), PVR grade C (OR 4.57, CI
1.68–12.42), and pulse pressure (OR 1.37, CI 1.03–1.83 per SD) were independently
associated with the occurrence of redetachment.
CONCLUSIONS. Skin autofluorescence and vitreous AGEs are not suitable to identify patients at
high risk for redetachment after vitrectomy surgery. Surface area of detachment greater than
50%, PVR grade C, and pulse pressure were associated with redetachment.
Keywords: skin autofluorescence, advanced glycation endproducts, rhegmatogenous retinal
detachment, proliferative vitreoretinopathy, pulse pressure
Rhegmatogenous retinal detachment (RRD) is a sight-threatening disease with an annual incidence of 18.2 per
100,000 in The Netherlands.1 Surgical treatment results in
primary reattachment of the retina in 64% to 94% of cases.2
Persistent detachments and redetachments are associated with
poor functional results. To some extent, preoperative findings
can be used to individualize the chance of success. An
important risk factor for redetachment is proliferative vitreo-
retinopathy (PVR).
Attempts to improve the outcome of surgical treatment of
RRD have been made by the intravitreal use of drugs in order to
prevent PVR. However, due to mixed results and/or retinal
toxicity, none of these have led to a safe or sufficiently effective
drug for routine use. Therefore, several studies have empha-
sized the need to identify high-risk patients who may benefit
from a specific treatment. Because of the complexity of risk
factors associated with the development of PVR, it is difficult to
identify patients at high risk.3
One factor that may play a role in retinal redetachment is
increased tissue glycation and the accumulation of advanced
glycation endproducts (AGEs), which are formed by glycation
and oxidation of free amino groups of proteins, lipids, and
nucleic acids. AGEs and their a-dicarbonyl precursors play a
role in several age-related conditions, such as atherosclerosis
and diabetes mellitus.4 Moreover, AGEs have been found at sites
of known ocular pathology.5 Currently, little is known about
AGEs in RRD patients, but some evidence exists for a role of
AGEs in the development of PVR.6 Both AGEs and AGE-
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receptors (RAGE) were increased in the vitreous of patients
with PVR and were present in their epiretinal membranes
(ERMs).7 Furthermore, AGEs can induce the expression of
several cytokines that have been shown to be elevated in
PVR.8–10
Considering the potential role of AGEs in PVR, AGEs might
represent a risk factor for retinal redetachment. AGE accumu-
lation can be estimated by skin autofluorescence (SAF), a
noninvasive technique that reflects AGE accumulation in
several tissues with slow turnover, such as the skin11,12 and
cardiac tissue.13 Skin autofluorescence is related to autofluo-
rescence of the lens and is elevated in patients with
neovascular AMD and diabetic retinopathy.5
The primary objective of the present study was to
investigate whether SAF, in combination with other clinical
characteristics, was able to identify patients at high risk for
retinal redetachment after vitrectomy. The secondary objective
was to investigate several vitreous AGEs and a-dicarbonyls in a
subgroup of patients in order to evaluate the potential relation
of systemic AGE accumulation with local eye disease.
METHODS
This study was designed as a prospective cohort study
consisting of RRD patients who were scheduled for trans pars
plana vitrectomy (TPPV) surgery. The research protocol was
approved by the Medical Ethics Committee of the University
Medical Center Groningen (UMCG; The Netherlands) and
adhered to the Declaration of Helsinki. The study was
registered in the Dutch Trial Register (NTR4289) and was
performed at the UMCG between November 2013 and August
2015. All participants gave their written informed consent.
Study Population
Adult patients visiting the Ophthalmology Department of the
UMCG and presenting with an RRD were invited to participate
in this study. Patients who were scheduled for primary TPPV,
but also patients undergoing vitrectomy after earlier cryother-
apy, photocoagulation, or scleral buckling procedures for
retinal breaks or small detachments, were included. The
following exclusion criteria were based on the presence of
conditions that are known to affect AGE levels or SAF
measurements: known renal disease with impairment of renal
function, dialysis treatment, history of renal transplantation,14
current infection or active inflammatory disease,15 skin
abnormalities on both forearms, and dark colored skin with
reflectance less than 8%. Clinical data and general character-
istics were obtained by chart review and questionnaires. The
smoking variable was divided into two groups: (1) never
smoker and previous smoker, and (2) current smoker. General
practitioner data were obtained for medical history of the
patients and pharmacy data were obtained for medication use.
Using a sphygmomanometer, blood pressure was measured in
a seated position by auscultation of the brachial artery. Pulse
pressure, as a global systemic measure for arterial stiffness, was
calculated as systolic blood pressure minus diastolic blood
pressure.
Standard Laboratory Assessments
Nonfasting venous blood was collected by venipuncture.
Serum creatinine, C-reactive protein (CRP), plasma glucose,
and HbA1c were measured using standard procedures. Renal
function was evaluated by estimated glomerular filtration rate
(eGFR) calculated by the modification of diet in renal disease
formula: eGFR¼ 1863 [serum creatinine (lM)3 0.0113]1.154
3 age–0.203 (3 0.742 for women). C-reactive protein was
measured to ensure that no active infection or inflammatory
disease was present, because this could affect AGE accumula-
tion.15 Diabetes mellitus was defined by criteria from the
American Diabetes Association16 or twice measured values of
HbA1c greater than or equal to 48 mmol/mol.
Vitrectomy Procedure
At the start of a standard three-port trans pars plana vitrectomy
procedure, undiluted vitreous samples were collected from the
midvitreous by aspirating the vitreous manually through a
syringe connected to the vitrectome. The samples were frozen
within 15 to 30 minutes and stored at808C until further use.
After fluid-air exchange and subretinal fluid drainage from the
causative retinal tear(s) or iatrogenic hole, intraoperative laser
coagulation, and/or cryotherapy were applied to the causative
retinal tear(s) and/or iatrogenic hole. Based on clinical
presentation, either 20% sulfur hexafluoride (SF6), 15%
octafluorpropane (C3F8), or 5000 centistokes silicone oil
was used as tamponade agent. In case of silicone oil, a second
procedure was needed to remove the oil. Individual features of
the surgery, such as use of cryotherapy or internal limiting
membrane peeling, were documented in the surgical report.
Ophthalmic Characteristics
Characteristics of retinal detachment were determined during
surgery. Surface area of detached retina in relation to total
retinal surface was scored in quartiles. Proliferative vitreoret-
inopathy (PVR) was graded A to C, according to the Retina
Society PVR classification.17 The number of retinal defects and
presence of vitreous bleeding were also scored. Furthermore,
duration of detachment was approximated by asking the
patient about duration of visual field loss. Our main outcome
was defined as a redetachment within 3 months after the
vitrectomy procedure. In case of silicone oil use, the main
outcome was defined as a redetachment within 3 months after
removal of the oil. The timeframe of 3 months was chosen
because redetachments due to PVR usually occur shortly after
the tamponade no longer exerts pressure to the retina.
Furthermore, the majority of redetachments of all causes
(85%) occur within 90 days after vitrectomy.18
Skin Autofluorescence
Skin autofluorescence was measured on the left forearm using
the AGE Reader (DiagnOptics Technologies BV, Groningen,
The Netherlands), a noninvasive desktop device using the
characteristic fluorescent properties of certain AGEs to
estimate the level of AGE accumulation in the skin. Technical
details concerning the optical technique have been extensively
described elsewhere.19 Because SAF measurements may be
influenced by the use of skin products,20 patients were asked
about their recent use. When patients used skin tanners up to
14 days or sunscreen up to 7 days before SAF measurements,
SAF measurements were repeated on another day. When
patients used body lotion or other skin products up to 4 days
before SAF measurements, the lower arm was cleaned with
water and soap or alcohol 70%. Skin autofluorescence values
are expressed in arbitrary units (AU).
Measurement of AGEs and a-Dicarbonyls in
Vitreous Samples
Vitreous samples of 45 patients with a retinal redetachment
were analysed and compared with samples of 45 patients
without a redetachment, matched on age,21 eGFR, diabetes
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mellitus, smoking,22 intraocular lens implantation,6 and PVR.6,7
Measurement methods of AGEs and a-dicarbonyls have been
described in detail elsewhere: pentosidine was measured using
HPLC with a fluorescence detector23; lysine and protein-bound
Ne-(carboxymethyl)lysine (CML), Ne-(carboxyethyl)lysine
(CEL), and 5-hydro-5-methylimidazolone (MG-H1) were mea-
sured using ultra performance liquid chromatography tandem
mass spectrometry (UPLC MS/MS)24; derivatized 3-deoxyglu-
cosone (3-DG), methylglyoxal (MGO), and glyoxal (GO) were
analyzed by UPLC MS/MS.25
Statistical Analysis
A study population with a minimum of 50 subjects with retinal
redetachment was pursued to be able to construct a regression
model in which correction for five confounders would be
allowed. Data are presented in percentages, as mean and SD, or
as median and interquartile range (IQR). Differences between
redetachment patients and controls were tested using v2 tests
for categorical variables, t-tests for normally distributed
continuous variables, and Mann-Whitney U tests for remaining
variables. Using the backward stepwise method, a multivari-
able logistic regression model was developed relating risk
factors identified by univariable analysis (P < 0.1) to the risk of
redetachment. Statistical significance was accepted at P less
than 0.05. Statistical analyses were performed using SPSS
version 22 (IBM Corp., Armonk, NY, USA).
RESULTS
A total of 410 RRD patients were included in the study. Before
analysis, five patients were excluded: four patients underwent
scleral buckling procedures instead of vitrectomy and one
patient still had silicon oil in situ at the end of the study.
Therefore, 405 patients remained for analysis. Of these
patients, 366 underwent vitrectomy, 1 patient underwent a
combined vitrectomy/scleral buckling procedure, and 38
underwent a combined vitrectomy/cataract surgery. A re-
detachment within 3 months occurred in 53 patients, leaving
352 patients in the control group. Clinical and biochemical
characteristics of the study population stratified for redetach-
ment and controls are shown in Table 1.
General Characteristics
Patients who developed a redetachment were significantly
older, had higher systolic blood pressure, and had higher pulse
pressure. Sex, body mass index, smoking, and presence of
diabetes mellitus were not different between the two groups.
Ophthalmic Characteristics
More patients with an intraocular lens implantation developed
a retinal redetachment compared with phakic patients.
Furthermore, retinal detachment surface of greater than 50%
was associated with retinal redetachment. Although patients
with PVR grades B and C tended toward an association with
retinal redetachment, it appeared that only patients with PVR
grade C contributed to this association. Detachment duration
and number of retinal breaks were not different between the
two groups.
Skin Autofluorescence
Before analysis of the relation between skin autofluorescence
and redetachment, some additional patients had to be
excluded with known confounders for SAF measurement.
Two patients were excluded with CRP greater than 20 mg/L
and five patients were excluded because of the use of skin
products without proper cleaning of the forearm or logistic
failure of repeating the measurement on another day.
Furthermore, two patients did not have SAF values since SAF
could not be measured by the AGE Reader (probably due to
reflectance < 8%). Therefore, SAF values of 50 redetachment
patients were compared with 346 control patients. Skin
autofluorescence did not differ significantly between redetach-
ment patients and controls. After correction for age, eGFR, and
diabetes mellitus, SAF values were still comparable between
redetachment patients and controls (odds ratio [OR]¼ 0.79, P
¼ 0.457).
Vitreous AGEs and a-Dicarbonyls
Biochemical characteristics of the vitreous are shown in Table
2. None of the measured protein-bound AGEs, free AGEs, or a-
dicarbonyls were significantly elevated in the redetachment
patients.
Multivariable Analysis
A binomial logistic regression analysis was performed to
ascertain the effects of age, systolic blood pressure, pulse
pressure, previous intraocular lens implantation, surface area
of detachment, and PVR grade C on the likelihood that
participants developed redetachment of the retina. Consider-
ing that choice of tamponade strongly depends on clinical






n ¼ 352† P Value
Age, y 64 6 9.6 61 6 9.4 0.024
Sex, male, % 64.2 69.3 0.450
BMI, kg/m2 26 6 4.0 26 6 3.8 0.925
Systolic blood pressure,
mm Hg 135 (130–154) 130 (124–145) 0.017
Pulse pressure, mm Hg 56 (49–65) 50 (45–60) 0.022
Current smoker, % 11.3 13.7 0.639
Diabetes mellitus, % 13.2 9.4 0.383
Intra ocular lens
implantation, % 47.2 31.3 0.022
Surface area of
detachment >50%, % 62.3 33.4 <0.001
PVR grades B & C, % 22.6 13.1 0.065
PVR grade C, % 17.0 2.8 <0.001
Detachment duration, d 8 (5–17) 7 (5–13) 0.076
Retinal breaks, n 2 (1–3) 2 (1–4) 0.252
Vitrectomy/vitrectomy þ
cataract, % 84.9/15.1 91.5/8.5 0.126
Tamponade gas/oil, % 78.8/21.2 93.8/6.3 <0.001
Cryotherapy, % 81.1 82.4 0.824
ILM peeling, % 34.0 25.3 0.182
Nonfasting glucose, mM 5.9 (5.5–6.5) 5.8 (5.4–6.7) 0.714
HbA1c, mmol/mol 38 (35–42) 38 (36–41) 0.864
eGFR, mL/min 84 6 17.4 85 6 15.3 0.562
Skin autofluorescence, AU 2.42 6 0.46 2.36 6 0.53 0.431
BMI, body mass index; ILM, internal limiting membrane. For
categorical variables, data are displayed as percentages and P values are
based on v2 tests. For normally distributed continuous variables, data
are given as mean 6 SD and P values are based on t-tests. For remaining
variables, data are shown as median (IQR) and P values are based on
Mann-Whitney U tests.
* For skin autofluorescence, n¼ 50.
† For skin autofluorescence, n¼ 346.
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presentation of retinal detachment, tamponade was not kept as
a criterium for analysis. Furthermore, the strong correlation
between systolic blood pressure and pulse pressure (r¼ 0.793,
P < 0.001) did not allow both variables in the same model.
Therefore, the multivariable analysis was performed twice and
the final model was chosen based on Nagelkerke R2 and model
v2. In the final model (Table 3), three variables significantly
contributed to the prediction of redetachment: pulse pressure,
surface area of detachment, and PVR grade C. The model
explained 13.3% (Nagelkerke R2) of the variance in redetach-
ment. Patients with area of detachment greater than 50% had
2.7 higher odds to develop a redetachment than patients with
area of detachment less than 50%. Patients with PVR grade C
had 4.6 higher odds to develop a redetachment than patients
with PVR grades 0 to B.
DISCUSSION
This study addressed whether systemic and vitreous AGE
accumulation, in combination with other potential risk factors,
including disease characteristics, surgical procedures, and
blood pressure, were associated with the development of
redetachment after vitrectomy for RRD. The results show that
neither SAF nor vitreous AGE levels predicted redetachment in
our study population.
These findings were unexpected, because of the potential
role of AGEs in PVR in combination with the anticipated high
proportion of redetachments due to PVR. In previous research,
a relation has been found between PVR grade and vitreous
pentosidine in RRD patients.6 A pilot study performed by our
study group indicated that both SAF and vitreous pentosidine
were elevated in patients with PVR grades B or C.26
Furthermore, both AGEs and RAGE were increased in the
vitreous of patients with PVR and were present in their ERMs.7
The suggested pathway by which AGEs may play a role in PVR
is through activation of RAGE in myofibroblasts located in
ERMs.27 These myofibroblasts are proposed to play a key role
in fibrosis by contributing to tissue contraction and by
producing extracellular matrix components.28 Furthermore
AGEs may play a role in PVR through the induction of several
cytokines that are elevated in PVR (e.g., monocyte chemo
attractant protein-1 [MCP-1] and VEGF).8–10
Several factors should be considered when interpreting our
results in the context of previous AGE studies in PVR. In the
present study, AGE accumulation was not investigated in
patients with redetachments due to PVR alone, but to
redetachments of any cause. Furthermore, the selection of
tamponade during vitrectomy based on clinical presentation
may have played a role. Patients with preoperatively present
PVR grades B and C were more likely to receive oil tamponade,
which may have reduced the risk of redetachment in these
patients. Another important consideration is that ‘local’ AGEs
were measured in the vitreous, which was removed during
surgery. Therefore, the measured levels of AGEs may not reflect
local AGE levels during the follow-up period. Considering these
factors, the results of this study do not exclude a role of AGEs
in PVR.
Concerning the risk factors for redetachment that were
observed in this cohort study, the results were largely in
agreement with previous studies. Although a variety of risk
factors have been identified, the extent of detached retina and
PVR grade C are characteristics that usually emerge as
important risk factors.29–32 Likewise, our results show that
more patients develop a redetachment when the surface area
of detachment is greater than 50% and when PVR grade C is
present. Concerning increasing age and previous intraocular
lens implantation as risk factors for redetachment, mixed
results have been shown previously.29,33 Therefore, it was not
surprising that these factors were no longer significant in our
multivariable analysis. Probably, these factors contribute to re-
detachment through influencing other risk factors considering
the reciprocal correlations (data not shown). To illustrate, age
was correlated with area of detachment (r¼ 0.189, P < 0.001)
and pulse pressure (r¼ 0.308, P < 0.001), and intraocular lens
implantation was correlated with area of detachment (r ¼
0.165, P ¼ 0.001).
Although arterial stiffness is not often considered as a risk
factor for retinal redetachment, our results indicate that pulse
pressure independently contributes to the development of
redetachment after vitrectomy. If this observation would be
confirmed in other cohorts, it could be recommended to
screen RRD patients for untreated hypertension and increased
pulse pressure in the preoperative evaluation of vitrectomy
patients in addition to the establishment of disease character-
istics. Though it seems obvious to regulate the blood pressure
properly, it should be further investigated whether this would
also lead to risk reduction of redetachments. A possible
mechanism in which elevated pulse pressure could contribute






n ¼ 45 P Value
Age, y 64 6 9.7 64 6 9.5 0.948
eGFR, mL/min 84 6 18.1 86 6 14.8 0.648
Diabetes mellitus, % 11.1 13.3 0.748
Current smoker, % 13.3 8.9 0.502
Intra ocular lens
implantation, % 51.1 46.7 0.673
PVR grades B & C, % 17.8 20.0 0.788
Lysine, mM 0.66 (0.40–1.63) 0.55 (0.39–1.05) 0.451
Protein-bound AGEs
Pentosidine, nmol/
mmol lysine 1.59 (1.24–2.78) 1.91 (1.19–2.70) 0.971
CML, nmol/mmol
lysine 227 (176–341) 232 (182–295) 0.696
CEL, nmol/mmol
lysine 128 (86–207) 122 (66–164) 0.061
MG-H1, nmol/
mmol lysine 670 (452–1434) 698 (352–1076) 0.355
Free AGEs
CML, nM 77 (56–93) 77 (59–92) 0.580
CEL, nM 66 (53 – 77) 67 (50–82) 0.726
MG-H1, nM 171 (128–224) 179 (125–244) 0.850
a-dicarbonyls
3-DG, nM 648 (533–787) 602 (523–785) 0.485
MGO, nM 235 (193–270) 234 (200–282) 0.850
GO, nM 426 (248–628) 490 (309–660) 0.300
Data are shown as median (IQR) and P values are based on Mann-
Whitney U tests.
TABLE 3. Parameters of the Multivariable Model Independently
Related to Redetachment Less Than 3 Months
Characteristic OR 95% CI P Value
Surface area of detachment > 50% 2.74 1.45–5.17 0.002
PVR grade C 4.57 1.68–12.42 0.003
Pulse pressure 1.37* 1.03–1.83* 0.031
Nagelkerke R2 ¼ 13.3%; Model v2 ¼ 29.21, P < 0.001.
* OR is expressed per 1-SD increase of pulse pressure.
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to redetachments in RRD patients would be comparable to
proposed mechanisms in which untreated hypertension could
lead to serous retinal detachments34 and central serous
chorioretinopathy35: elevated blood pressure leads to in-
creased intravascular pressure, which may cause changes in
the retinal pigment epithelium (RPE) that impairs the RPE-
mediated drainage of subretinal fluid.
A major strength of the current study is the measurement of
several AGEs and a-dicarbonyls with state-of-the-art techniques
based on UPLC MS/MS. Moreover, free AGEs were measured in
addition to protein-bound AGEs. Because free AGEs are
breakdown products of protein-bound AGEs, the absence of
elevated levels of free AGEs indicates that the lack of
differences in protein-bound CML, CEL, and MG-H1 is not a
result of differences in degradation of these products.
Furthermore, we prospectively investigated a relatively unse-
lected and large cohort in a single-center study, which would
be representative for the Dutch RRD population in the
northern part of The Netherlands.
A limitation of our study was the selection of redetachment
patients due to any cause instead of PVR only. This choice was
made because it would be clinically more relevant to be able to
identify any patient with a redetachment than just a subgroup.
Also, the follow-up time of 3 months after vitrectomy might be
a limitation. However, approximately 85% of the redetach-
ments of all causes occur within 90 days after vitrectomy.18 For
redetachments due to PVR, this proportion is probably even
higher. The study size for comparing vitreous levels of AGEs in
redetachment patients and matched controls might be too
small to detect differences, because our sample size was based
on the construction of a regression model for SAF. However,
the clinical relevance would be limited if it would be necessary
to investigate an even larger cohort. The results concerning
free AGEs and a-dicarbonyls could be subject to sampling
errors, because the aging vitreous consists of areas of synchisis
and syneresis.36,37 Unfortunately, this is inevitable because
there is a limit to the undiluted vitreous that can be removed
safely from the eyes of patients, in particular from those with
RRD. Finally, since our study was not designed to investigate
the influence of pulse pressure on redetachment in RRD
patients, this could be a coincidental finding.
In conclusion, SAF and vitreous AGEs are not able to
identify patients at high risk of retinal redetachment after
vitrectomy surgery. In addition to surface area of detachment
greater than 50% and PVR grade C, pulse pressure was
observed as a risk factor for redetachment. Before any
recommendations can be given, the value of this potential
new biomarker should be established in other cohorts of RRD
patients.
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